Ligand Pharmaceuticals acquires milestones and royalties for MEDI-528 from Genaera Liquidating - MarketLine Financial Deals

Ligand Pharmaceuticals acquires milestones and royalties for MEDI-528 from Genaera Liquidating

Ligand Pharmaceuticals acquires milestones and royalties for MEDI-528 from Genaera Liquidating - MarketLine Financial Deals
Ligand Pharmaceuticals acquires milestones and royalties for MEDI-528 from Genaera Liquidating
Published May 21, 2010
2 pages — Published May 21, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Ligand Pharmaceuticals Incorporated, a biotechnology company, has acquired certain intellectual property and interests in future milestones and royalties for MEDI-528 from the Genaera Liquidating Trust.

  
Source:
Document ID
MA25811_100528
Country
Ticker
GENR=US
Ticker
LGND=US
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Ligand Pharmaceuticals acquires milestones and royalties for MEDI-528 from Genaera Liquidating" May 21, 2010. Alacra Store. Dec 02, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Ligand-Pharmaceuticals-acquires-milestones-and-royalties-for-MEDI-528-from-Genaera-Liquidating-2052-33755>
  
APA:
MarketLine Financial Deals. (2010). Ligand Pharmaceuticals acquires milestones and royalties for MEDI-528 from Genaera Liquidating May 21, 2010. New York, NY: Alacra Store. Retrieved Dec 02, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Ligand-Pharmaceuticals-acquires-milestones-and-royalties-for-MEDI-528-from-Genaera-Liquidating-2052-33755>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.